Similar to somatic CML LSCs, day 9 CML iPSC-derived CD45+ cells had ALDH activity and were able to efflux Rhodamine-123 (Fig. 1c-d). This evidence concerns the gene PTPRC and chronic myelogenous leukemia, BCR-ABL1 positive.